References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018Nov;682:394–424. PubMed PMID: 30207593; eng
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin . 2020 Jan;70(1):7–30. PubMed PMID: 31912902; eng.
- Papamichael D, Audisio RA, Glimelius B, et al. Treatment of colorectal cancer in older patients: international Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2015Mar;263:463–476. PubMed PMID: 25015334; eng
- Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science (New York, NY). 2013 Mar 29;339(6127):1546–1558. PubMed PMID: 23539594; PubMed Central PMCID: PMCPMC3749880. eng
- Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016Mar-Apr;662:115–132. PubMed PMID: 26808342; eng
- O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004 Oct 6;96(19):1420–1425. PubMed PMID: 15467030; eng.
- Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012 May 25;149(5):1060–1072. PubMed PMID: 22632970; PubMed Central PMCID: PMCPMC3367386. eng.
- Stockwell BR, Jiang X, Gu W. Emerging Mechanisms and Disease Relevance of Ferroptosis Trends Cell Biol . 2020 Jun;30(6):478–490. PubMed PMID: 32413317; PubMed Central PMCID: PMCPMC7230071. eng.
- Xie Y, Zhu S, Song X, et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Rep. 2017 Aug 15;20(7):1692–1704. PubMed PMID: 28813679; eng.
- Chen P, Li X, Zhang R, et al. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10(11):5107–5119. PubMed PMID: 32308771; PubMed Central PMCID: PMCPMC7163451. eng.
- Wei G, Sun J, Hou Z, et al. Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway. Eur J Med Chem. 2018 Sep 5;157:759–772. PubMed PMID: 30142612; eng.
- Lee YS, Lee DH, Jeong SY, et al. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5. J Cell Biochem. 2019Jan;121:928–939. PubMed PMID: 30160785; PubMed Central PMCID: PMCPMC6249082. eng
- Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019May;5697755:270–274. PubMed PMID: 31043744; PubMed Central PMCID: PMCPMC6533917. eng
- Dai E, Han L, Liu J, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway. Nat Commun. 2020 Dec 11;11(1):6339. PubMed PMID: 33311482; PubMed Central PMCID: PMCPMC7732843. eng.
- Du X, Zhang Y. Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma. Front Genet. 2020;11:614888. PubMed PMID: 33391356; PubMed Central PMCID: PMCPMC7775557. eng.
- Chou TC. Preclinical versus clinical drug combination studies. Leuk Lymphoma. 2008Nov;49(11):2059–2080. PubMed PMID: 19021049; eng.
- Dienstmann R, Salazar R, Tabernero J. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. J Clin Oncol. 2015 Jun 1;33(16):1787–1796. PubMed PMID: 25918287; eng.
- Kumagai T, Matsukawa N, Kaneko Y, et al. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem. 2004 Nov 12;279(46):48389–48396. PubMed PMID: 15355999; eng.
- Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016 Jan 12;23(1):27–47. PubMed PMID: 26771115; PubMed Central PMCID: PMCPMC4715268. eng.
- Bardelli A, Siena S. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol. 2010 Mar 1;28(7):1254–1261. PubMed PMID: 20100961; eng.
- Misale S, Di Nicolantonio F, Sartore-Bianchi A, et al. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution. Cancer Discov. 2014Nov;411:1269–1280. PubMed PMID: 25293556; eng
- Vodenkova S, Buchler T, Cervena K, et al. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020 Feb;206:107447. PubMed PMID: 31756363; eng
- Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019Jul;19(7):405–414. PubMed PMID: 31101865; eng.
- Wang Y, Zhao G, Condello S, et al. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis. Cancer Res. 2021 Jan 15;81(2):384–399. PubMed PMID: 33172933; PubMed Central PMCID: PMCPMC7855035. eng.
- Lee H, Zandkarimi F, Zhang Y, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020Feb;222:225–234. PubMed PMID: 32029897; PubMed Central PMCID: PMCPMC7008777. eng
- Li C, Dong X, Du W, et al. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis Signal Transduct Target Ther. 2020 Sep 3;5(1):187. PubMed PMID: 32883948; PubMed Central PMCID: PMCPMC7471309. eng.
- Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020Sep;5857826:603–608. PubMed PMID: 32939090; PubMed Central PMCID: PMCPMC8051864. eng
- Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017 Nov 9;551(7679):247–250. PubMed PMID: 29088702; PubMed Central PMCID: PMCPMC5933935. eng.
- Alvarez SW, Sviderskiy VO, Terzi EM, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017 Nov 30;551(7682):639–643. PubMed PMID: 29168506; PubMed Central PMCID: PMCPMC5808442. eng.
- Qian X, Tang J, Li L, et al. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma. Bioengineered. 2021Dec;121:2341–2351. PubMed PMID: 34077308; eng
- Qi X, Fu Y, Sheng J, et al. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer. Bioengineered. 2021Dec;121:1813–1825. PubMed PMID: 33989111; eng
- Shi ZZ, Habib GM, Rhead WJ, et al. Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet. 1996Nov;143:361–365. PubMed PMID: 8896573; eng
- Chafe SC, Vizeacoumar FS, Venkateswaran G, et al. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv. 2021 Aug;7(35). 10.1126/sciadv.abj0364. PubMed PMID: 34452919; PubMed Central PMCID: PMCPMC8397268. eng.